BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 18211567)

  • 1. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
    Gernsheimer T
    Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of chronic immune thrombocytopenic purpura.
    Cines DB; McMillan R
    Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of chronic immune thrombocytopenic purpura.
    McMillan R
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis.
    Wang L; Li Y; Hou M
    Crit Rev Oncol Hematol; 2007 Nov; 64(2):83-9. PubMed ID: 17900920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous platelet kinetics in patients with severe thrombocytopenia: discrimination between disorders of production and destruction.
    Tomer A; Hanson SR; Harker LA
    J Lab Clin Med; 1991 Dec; 118(6):546-54. PubMed ID: 1744503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura.
    Ichikawa N; Ishida F; Shimodaira S; Tahara T; Kato T; Kitano K
    Thromb Haemost; 1996 Aug; 76(2):156-60. PubMed ID: 8865522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis.
    Gernsheimer T
    Oncologist; 2009 Jan; 14(1):12-21. PubMed ID: 19144680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A megakaryocyte with no platelets: anti-platelet antibodies, apoptosis, and platelet production.
    Perdomo J; Yan F; Chong BH
    Platelets; 2013; 24(2):98-106. PubMed ID: 22742725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
    Nugent D; McMillan R; Nichol JL; Slichter SJ
    Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
    McMillan R
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.
    Arnold DM; Nazi I; Toltl LJ; Ross C; Ivetic N; Smith JW; Liu Y; Kelton JG
    Eur J Haematol; 2015 Dec; 95(6):532-7. PubMed ID: 25684257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.
    Lev PR; Grodzielski M; Goette NP; Glembotsky AC; Espasandin YR; Pierdominici MS; Contrufo G; Montero VS; Ferrari L; Molinas FC; Heller PG; Marta RF
    Br J Haematol; 2014 Jun; 165(6):854-64. PubMed ID: 24673454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thrombocytopenia of WAS: a familial form of ITP?
    Strom TS
    Immunol Res; 2009; 44(1-3):42-53. PubMed ID: 18854955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro megakaryocyte colony formation in patients with idiopathic thrombocytopenic purpura: differences between acute and chronic ITP.
    Abgrall JF; el-Kassar N; Berthou C; Renard I; Cauvin JM; Le Pailleur A; Autrand C; Sensebe L; Guern G; Zilliken P
    Int J Cell Cloning; 1992 Jan; 10(1):28-32. PubMed ID: 1552223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.
    Marini I; Bakchoul T
    Hamostaseologie; 2019 Aug; 39(3):227-237. PubMed ID: 30802916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of splenectomy on immune thrombocytopenic purpura in (NZW x BXSB) F1 mice: analyses of platelet kinetics and anti-platelet antibody production.
    Mizutani H; Furubayashi T; Kashiwagi H; Honda S; Take H; Kurata Y; Yonezawa T; Tarui S; Ikehara S
    Thromb Haemost; 1992 May; 67(5):563-6. PubMed ID: 1519215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura.
    McFarland J
    Blood Rev; 2002 Mar; 16(1):1-2. PubMed ID: 11913982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some unsettled questions in childhood thrombocytopenia caused by immunologic platelet destruction (acute and chronic ITP).
    Gaedicke G; Schulze H
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):668-70. PubMed ID: 16933247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic thrombocytopenic purpura.
    Palaniappan G; Jennings W
    Mo Med; 2009; 106(1):69-73. PubMed ID: 19245128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.